- AU$159.92m
- AU$150.65m
- AU$111.52m
- 79
- 48
- 99
- 87
Annual balance sheet for SomnoMed, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 21.1 | 15.6 | 12 | 16.2 | 17.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 8.22 | 9.2 | 9.03 | 8.24 | 14.1 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 34.1 | 30.3 | 27.5 | 35.1 | 43.1 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 10.3 | 9.12 | 12.7 | 11.1 | 13.9 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 56.2 | 58.1 | 62.5 | 69.8 | 81 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 16.2 | 23.8 | 18.4 | 19.9 | 28.6 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 24 | 30.3 | 40.1 | 24.8 | 34.6 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 32.2 | 27.8 | 22.4 | 45 | 46.4 |
| Total Liabilities & Shareholders' Equity | 56.2 | 58.1 | 62.5 | 69.8 | 81 |
| Total Common Shares Outstanding |